Beau's Lines and COVID-19: A Systematic Review on Their Association

March 2024 in “ Pathogens ”

Aris P. Agouridis, Christina Mastori-Kourmpani, Polyna Antoniou, Paschalis Konstantinou, Evangelos C. Rizos, Constantinos Tsioutis

Studysummary The systematic review reports an association between Beau’s lines and COVID-19 infection or vaccination, observing variability in onset and resolution times, and suggesting these nail disorders might indicate previous severe infection or vaccination, as well as potentially signify long COVID-19 syndrome.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Unravelling Beau's Lines as a Potential Indicator of Severe Immune Response in COVID-19 and Reinfection

2 citations , January 2024 in “European Journal of Case Reports in Internal Medicine”

The researchers reported a case of Beau's lines in a 65-year-old man, potentially linked to past severe COVID-19 infections, suggesting that identifying these nail changes might signal prior infection and increased risk of reinfection.

research The Effect of COVID-19 on Development of Hair and Nail Disorders: A Turkish Multicenter, Controlled Study

3 citations , October 2022 in “International Journal of Dermatology”

This multicenter study found that hair and nail disorders, particularly telogen effluvium, commonly developed in patients after severe COVID-19 infection.

research Transverse Leukonychia And Beau Lines Following COVID-19 Vaccination

2 citations , August 2022 in “Cutis”

This article suggests that nail abnormalities might occur temporarily after COVID-19 vaccination, but they are self-limiting and should not deter individuals from getting vaccinated.

research Case of De Novo Nail Psoriasis Triggered by the Second Dose of Pfizer-BioNTech BNT162b2 COVID-19 Messenger RNA Vaccine

28 citations , September 2021 in “JAAD Case Reports”

This study reports that the Pfizer-BioNTech COVID-19 vaccine showed 52% protection against COVID-19 after the first dose and 95% after the second in phase 3 trials.

research Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection

7 citations , June 2021 in “JAAD Case Reports”

This article reviews the cutaneous manifestations of COVID-19, highlighting their potential as early indicators of infection, and reports no new clinical results.